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whether the fiN case of MPLCs wa~ described by Beyreuther
in 1924, as mentioned by Okada and colleagues, I or whether
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Reply to the Editor:
It is our pleasure to address the points raised by YI1dlzeli
and associates in their letter regardmg our recently published
article, 1 We had already asses~ed the characteristics of small
non-small cell lung cancers with DNA ploidy. This study con-
sisted of 39% aneuploidy and 61 % diplOidy tumors and sug-
gested that DNA ploidy was a prognostic factor and that ane-
uploidy possessed occult malignancy, 2 However, we do not
think that the DNA ploidy IS the definitive answer to the
dilemma whether a tumor IS a second primary or a recurrence.
When the 2 tumors had completely different patterns of DNA
ploidy, they were defined as second primaries. However, as
shown in many previous reports,3.5 all specimens had normal
(diploid) peaks, which were made by tumor cells and normal
epithelial or stromal cells (or both) within tumors. Even with
cytofluorometric evaluation of lung cancer, which can theo-
retically select only tumor cells, most tumors contained nor-
mal peaks." Therefore we have speculated on the sensitivity
and specificity of the ploidy results regarding the differentia-
tion between second primaries and metastases. We have fol-
lowed the policy that lung-saving procedures such as bron-
choplasty for a primary leSIOn must always be kept in mind.
Of 671 patients who underwent operations for primary lung
cancer over a period of 6 years. we con~idered 39 patients to
have pT2 NI MO disease. None was subjected to pneu-
monectomy, and 14 (36'7c) underwent sleeve lobectomy
instead. We succeeded in preserving lung function with a rea-
sonable prognosis and a better postoperative quality of life,
which was proven by spirometry and treadmill exercise
test7 .8 Needless to say, pneumonectomy decreases the chance
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of a second pnmary sigmfICantly compared wilh lobectomy,
because removal of more lung tissue with the first tumor
',>,ould leave the patient With les~ lung tissue in which a sec-
ond pnmary could develop later. Preservation of lung func-
tion, however, is much more important than the risk of second
primary lesions.
A smoking index (cigarettes/day x years) of more than 600
at the time of diagnosis of the second tumor was recorded in
43 patient~ (75%), suggesting a remarkable incidence of
smoking among patients with multiple primary tumors. This
probably accounts for the high proportion of squamous cell
carcinoma~ in our series.
Chaudhuri,9 like US,l mentioned that Beyreuther descnbed
the first case of multiple primary lung cancer in 1924.
Morihito Okada, MD
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Profound systemic hypothermia and release of
neurotransmitter amino acids
To the Editor:
We read with great interest the article titled "Profound
Systemic Hypothermia Inhibits the Release of Neuro-
transmitter Ammo Acids in Spinal Cord Ischemia" by Rokkas
and associates (1 Thorac Cardiovasc Surg 1995:110:27-35).
Although considerable information IS provided, we believe It
needs to be placed in the proper perspective to lead to a cor-
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rect interpretation. It is unfortunate that only 2 sham animals
were operated on for each experimental group (that would
preclude using that information for any statistical analysi'J,
and the data are not reported but merely mentioned in the text:
"The control sham animals demonstrated stable baseline val-
ues of amino acid concentrations for at least 150 minutes. The
hypothermia sham animals (hypothermia without aortic cross-
clamping) exhibited time-course changes in dialysate amino
acid levels that were indistinguishable from the changes
observed in group 2 animals (hypothermia and aortic cross-
clamping)." Although the general time course might have had
the same trend, the values must have been different. If they
were not different, that knowledge would have been helpful
and informative for the readership. Had the data been report-
ed, we believe differences would have been noticed between
the clamped (group 2) and the sham (nonclamped) hypothennic
animals. It is also unfortunate that the main thrust was to com-
pare group 1 (nonnothennic ischemia) and group 2 (hypother-
mic Ischemia), with less weight given to comparison against
their own baselines. The baseline measurements for group 2
were taken only before cooling, which we think is inadequate
unless enough sham group data are provided to assess the
effects of hypothermia per se. Had enough consideration to
comparison again,t their baselines been given, some obvious
differences would have been noticed that might have helped in
the proper interpretation of the data shown in Table I.
Perhaps the most important informatIOn in this article con-
cerned the significant differences in adenosine concentrations
between groups I and 2 during the ischemic period. However,
because attention was focused on the excitatory amino acid
(glutamate), the adenosine data were not properly discussed.
Although Table I appears to show that the differences from
the baseline values were not Significant, our analysis proved
otherwise. Adenosine increased more than 4-fold during nor-
mothennlc ischemia, which is anticipated and in agreement
with reported facts in normothermic ischemia. but it was sig-
nificantly lower in the hypothermic group during ischemia, as
well as during each of the reperfusion times. With such an
increase in adenosine in the normothermic group, an increase
in taurine is expected, because adenosine releases taurine. I-3
Because only the baseline data for hypothermic conditions
are supplied (ie, just before clamping in group 2) and because
the sham group was not large enough to supply sufficient
data, adequate comparison is not possible. Hypothermia will
decrease the rate of all processes, taurine relem,e Illcluded,
and it would be improper to make comparisons agaillst the
baseline values measured under normothermiC conditions.
However, disregarding the effect of hypothermia per se on the
release of the various amino acids, adenosllle levels in group
2 are significantly lower than the normothermic baseline, low
enough to explalll at least partially why the taurine concen-
trations were also lower than the normothermic baseline
value. The decreased adenosine and glutamate levels in group
2 during ischemia might indeed represent the protective
effect of hypothermia, which prevented the degradation of
adenosine triphosphate to adenosine and the ischemia-
induced depolarization with its concomitant release of gluta-
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mate. It can be speculated that glutamate, y-aminobutyric acid,
and taurine metabolic production during hypothennia were
decreased. Apparently taurine is a co-product formed during
adenosine triphosphate degradation, which involves interaction
with the homocysteine-methionine cycle producing taurine as
an end co-product from decarboxylatIOn of cysteic acid.4.5
On the basis of the mentioned conSiderations, and although
the authors ,tate "the role of taurine in the spinal cord IS not
clear but It does not appear that taurine plays any significant
role in modulating the ischemic Illjury," the findings of the
study do not ,ubstantiate that assertion. Furthermore, the
study was not designed to prove or disprove the protective
effects of taurine. In their study taurine was never adminis-
tered to evaluate its effects. The release of taurine is part of
the natural defensive mechanism set in motion when excess
adenosine is formed, such as in ischemia or trauma to any area
of the central nervous system,6.7 spinal cord included. The fact
that taurine levels were found to be low does not indicate that
taunne does not have a protective role. What is actually indi-
cating IS that the concomitantly used protective strategy (in
this case profound levels of hypothermia) was effective in pre-
venting the activation of mechanisms that release taurine. We
even hypothesize that the levels of taurine could actually be
used as an indicator of whether protection was achieved when
using protective strategies not involving taurine administra-
tion. In fact, our recent experimental studies in rabbits have
shown that exogenous taurine enhances the protective effects
of hypothermia and confers significant protection in animals
with spinal cord normothermic ischemia as well.
If the temporal course of y-aminobutyric acid and gluta-
mate in the post-rewarming phase of a large enough sham
group of hypothermic animals is similar to that of group 2,
the effect of hypothermia is not limited to the release of glu-
tamate during the ischemic period only. Since it is known that
mild or moderate degrees of hypothermia are effective in
decreasing the release of glutamate during ischemia, it would
be of interest to see whether such late effects are also
observed with mJld or moderate degrees of hypothermia
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Reply to the Editor:
It is somewhat surprising and quite unusual to receive a let-
ter about an article that we published in the Journal more than
3 years ago. The fast-paced developments in neuroscience
make It somewhat difficult to put the findings of an older
study in perspective, In our article titled "Profound Systemic
Hypothermia Inhibits the Release of Neurotransmitter Amino
Acids in Spinal Cord Ischemia" (J Thorac Cardiovasc Surg
1995;1 10:27-35), we simply described the findings of a study
designed to clarify the role of excitotoxicity in spinal cord
ischemia and a possible mechanism for the protective effect
of hypothermia, For the first time in the spinal cord, amino
acid levels were measured under conditions simulating the
clmical situation, and several of the findings broke new
ground in this field. More recent studies put those findings in
a proper perspective, describing mechanbms that qUIte sim-
ply were unknown at the time of publication of our article.
Our paper is criticized for not discussing references that
appeared in the literature after the paper was published. The
authors of the letter also claim that they re-analyzed statisti-
cally our data and reached different results, mdirectly imply-
ing that our statistical methods were flawed. We wonder.
however, how they were able to perform statistical analysis
Without havmg the raw data. In the data table, we provided
mean values and standard deviations for the various expen-
mental groups. The statistical analysis was performed by tak-
ing into conSideration the results from individual experi-
ments. Any analysis that compares only mean values of
different groups is simply not accurate. We also wish to point
out that sham animals served for validation of methodology
only, without per se constituting an experimental group. It is
a commonly accepted practice to use baseline values as con-
troL so long as they do not differ statistically among the
experimental groups.
The field of ischemia and neuronal cell death has expanded
the horizons of neuroscience tremendously in recent years.
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We believe our article provided some msights into the patho-
physiology of spinal cord ischemia.
Chris K. Rokkas. MD
Nicholas T. Kouchoukos, MD
Cardiac, Thoracic & Vascular Surgery Inc.
3009 North Ballas Rd
Suite 266 C
St Louis, MO 63131
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Left subclavian artery as a site of proximal aortic
perfusion for hypothermic repair of thoracic and
thoracoabdominal aneurysms
To the Editor:
Retrograde aortic perfusion through the femoral artery with
deep hypothermic circulatory arrest is a valuable adjunct for
thoracic and thoracoabdominal aneurysms. I However, retro-
grade perfusion of the brain through an atheromatous or dis-
sected aorta carries the risk of cerebral embolism or malper-
fusion. To avoid these fatal complications, Westaby and
Katsumata2 proposed a proximal aortic perfusion through the
ascending aorta or aortic arch via an extended left thoracoto-
my. However, the possibility exists that cerebral emboli may
be produced even by external manipulation of an atheroma-
tous aorta or aneurysm. Hence we have recently adopted a
proximal aortic perfusion technique usmg a prosthetic graft
attached to the left subclavian artery via a left posterolateral
thoracotomy for hypothermic thoracic and thoraco-abdomi-
nal aneurysm repair (Fig I). The left subclavian artery with
easy access from a thoracotomy has been used for a sys-
temic-pulmonary arterial shunt using a prosthetic graft in
neonates or small infants. 3 Moreover, the axillary artery is
also widely known as an alternative site for proximal arterial
Fig 1. Left subclavian artery (LSA) cannulation technique
through a posterolateral thoracotomy. After proximal and dis-
tal control of the LSA is obtained, an 8-mm sealed woven
Dacron graft is attached to the LSA. followed by cannulation
with a polyvinyl arch cannula. Venous drainage is through a
straight venous cannula placed in the main pulmonary artery
(PA).
